Haemonetics Corporation (NYSE:HAE) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds. On January 12, Michael Petusky from Barrington maintained his Outperform rating on Haemonetics Corporation (NYSE:HAE). He also revised his estimated price target upward from $90 to $93, implying an upside of almost 41%. Easiest Md/PhD Programs to Get Into oatautta/Shutterstock.com Petusky’s rating and target price adjustment came at the back of the company’s recent acquisition of Vivas ...